Sarepta Craters as FDA Considers Requesting Halt to Elevidys Shipments
A 3rd loss of life linked to Sarepta Therapeutics’ gene remedy platform reported Thursday will be the ultimate straw for...
Pharmaceutical Updates
MHRA approves needle-free adrenaline nasal spray for anaphylaxis
Anaphylaxis is a sudden, extreme and sometimes life-threatening allergic response that causes a drop in blood stress and respiration difficulties....
STAT+: Up and down the ladder: The most recent comings and goings
Employed somebody new and thrilling? Promoted a rising star? Lastly solved that hard-to-fill spot? Share the information with us, and...
BMS, Pfizer Be part of DTC Pattern, Providing Eliquis to Sufferers for 40% Under Listing Worth
Bristol Myers Squibb and Pfizer are making ready to promote the blockbuster blood thinner Eliquis, a top-selling drug in 2024...
Ten years of Uncommon Pediatric Illness Designation: impression on drug approvals
As a consequence of considerations surrounding its effectiveness, the US Meals and Drug Administration (FDA) ended the Uncommon Pediatric Illness...
We’re studying about Trump and pharma tariffs, abortion tablet ruling
Howdy, everybody, and the way are you right now? We're doing simply wonderful, thanks, particularly because the center of the...
Audrey Greenberg: Out to Change the World, From Housing to Healthcare
Audrey Greenberg’s profession has been outlined by being in the correct place on the proper time—and generally, the fallacious place...
Vertex and NHS England signal reimbursement settlement
Alyftrek is a triple-combination remedy meant for cystic fibrosis. Credit score: Jo Panuwat D/Shutterstock. Vertex Prescription drugs has introduced a...
We’re studying about GLP-1 medicine for habit, FDA funding
Good morning, everybody, and welcome to a different working week. We hope the weekend respite was stress-free and invigorating, as...
Weight problems in Focus: ADA Reveals R&D Priorities for Blockbusters-in-Ready
Regardless of not being within the occasion title, weight reduction and weight problems took heart stage on the just lately...
Actual-world proof as a strategic entry lever in uncommon illness drug growth
Greater than 30 million folks throughout Europe dwell with a uncommon illness, but fewer than 5% of those situations have...
STAT+: Up and down the ladder: The newest comings and goings
Employed somebody new and thrilling? Promoted a rising star? Lastly solved that hard-to-fill spot? Share the information with us, and...
Capricor Plunges on FDA Rejection of DMD Cell Remedy
The FDA has turned down Capricor Therapeutics’ investigational cell remedy deramiocel for the therapy of cardiomyopathy related to Duchenne muscular...
FDA points greater than 200 CRLs for transparency
The primary set of printed letters associated to beforehand authorized functions are accessible by way of openFDA. Credit score: Tada...
STAT+: Brawl over Eylea will get biosimilar trade’s consideration
Wish to keep on prime of the science and politics driving biotech immediately? Join to get our biotech e-newsletter in your inbox....
